Pablo Antonio Sánchez Salcedo-rekin lankidetzan egindako argitalpenak (16)

2022

  1. Emphysema: the risk of cancer and the impact on cancer care

    ERS Monograph, Vol. 2022, Núm. 98, pp. 105-117

2020

  1. Prevalence and burden of bronchiectasis in a lung cancer screening program

    PLoS ONE, Vol. 15, Núm. 4

2019

  1. Emphysema phenotypes and lung cancer risk

    PLoS ONE, Vol. 14, Núm. 7

2017

  1. Clinical Features of Smokers With Radiological Emphysema But Without Airway Limitation

    Chest, Vol. 151, Núm. 2, pp. 358-365

  2. Telomere length, COPD and emphysema as risk factors for lung cancer

    European Respiratory Journal

2016

  1. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT

    Lung Cancer, Vol. 97, pp. 81-86

  2. Is COPD a progressive disease? A long term BODE cohort observation

    PLoS ONE, Vol. 11, Núm. 4

  3. The neutrophil to lymphocyte and platelet to lymphocyte ratios as biomarkers for lung cancer development

    Lung Cancer, Vol. 97, pp. 28-34

2015

  1. BODE Index: A Good Quality of Life Marker in Chronic Obstructive Pulmonary Disease Patients

    Archivos de Bronconeumologia, Vol. 51, Núm. 7, pp. 311-312

  2. COPD comorbidities network

    European Respiratory Journal, Vol. 46, Núm. 3, pp. 640-650

  3. Efectos inmunomoduladores del glatirámero acetato y su potencial papel en la reactivación de la tuberculosis pulmonar

    Archivos de Bronconeumologia

  4. Improving selection criteria for lung cancer screening: The potential role of emphysema

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 8, pp. 924-931

  5. Lung Cancer Screening: Fourteen Year Experience of the Pamplona Early Detection Program (P-IELCAP)

    Archivos de Bronconeumologia, Vol. 51, Núm. 4, pp. 169-176

  6. Lung cancer in patients with chronic obstructive pulmonary disease: Development and validation of the COPD lung cancer screening score

    American Journal of Respiratory and Critical Care Medicine, Vol. 191, Núm. 3, pp. 285-291

2014

  1. Disease progression in young patients with COPD: Rethinking the Fletcher and Peto model

    European Respiratory Journal, Vol. 44, Núm. 2, pp. 324-331

  2. Prognostic evaluation of copd patients: Gold 2011 versus bode and the copd comorbidity index cote

    Thorax, Vol. 69, Núm. 9, pp. 799-804